Zenas BioPharma is a company committed to enabling patients with autoimmune diseases to reimagine their lives through the development of immunology-based therapies. The company is advancing immunology programs for multiple autoimmune diseases, with a focus on Obexelimab, a bifunctional monoclonal antibody that suppresses B cell activity, a contributor to many autoimmune diseases. Zenas BioPharma emphasizes the importance of addressing unmet medical needs and is progressing Obexelimab through clinical trials. With a dedicated team, Zenas BioPharma is poised to lead in the development and commercialization of transformative therapies for autoimmune diseases.
Autoimmune Diseases and Immunology
October 31
Associate Director for Medical Science Liaison at a global biopharmaceutical company.
πΊπΈ United States β Remote
π΅ $172k - $215k / year
π° $118M Series B on 2022-11
β° Full Time
π Senior
π Director
π¦ H1B Visa Sponsor